Generic Infectious Disease Pharmaceuticals Offer Potential In Sub-Saharan Africa
The markets for generic infectious disease pharmaceuticals in sub-Saharan Africa hold considerable potential. Despite high levels of poverty and market price sensitivity, the region has a large and growing population that is increasingly able to pay for better health services and pharmaceutical products. New analysis from growth consulting company Frost & Sullivan (http://www.pharma.frost.
More: continued here
Filed under: Infectious Diseases / Bacteria / Viruses on March 15th, 2008